Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Healthcare Sector Analysis

UpdatedJul 09, 2025
DataAggregated Company Financials
Companies21
  • 7D2.3%
  • 3M10.7%
  • 1Y-49.7%
  • YTD-27.3%

Over the last 7 days, the Healthcare industry has risen 2.3%, driven by gains from Novo Nordisk of 2.6%. In the past year, the industry is down 50%. Looking forward, earnings are forecast to grow by 12% annually.

Sector Valuation and Performance

Has the Danish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 09 Jul 2025DKK 2.5tDKK 423.0bDKK 124.5b30.7x19.7x5.8x
Fri, 06 Jun 2025DKK 2.6tDKK 423.7bDKK 124.6b30.8x20.7x6.1x
Sun, 04 May 2025DKK 2.5tDKK 409.3bDKK 121.3b23x20.6x6.1x
Tue, 01 Apr 2025DKK 2.6tDKK 409.5bDKK 121.3b23.1x21.1x6.2x
Thu, 27 Feb 2025DKK 3.4tDKK 410.0bDKK 121.4b28.8x28x8.3x
Sat, 25 Jan 2025DKK 3.3tDKK 387.4bDKK 111.3b29.4x29.8x8.6x
Mon, 23 Dec 2024DKK 3.1tDKK 387.4bDKK 111.3b28.7x28.2x8.1x
Wed, 20 Nov 2024DKK 3.8tDKK 387.3bDKK 111.3b32.1x33.8x9.7x
Fri, 18 Oct 2024DKK 4.2tDKK 372.1bDKK 107.2b37.3x39.2x11.3x
Sun, 15 Sep 2024DKK 4.7tDKK 372.0bDKK 107.1b36x43.8x12.6x
Tue, 13 Aug 2024DKK 4.6tDKK 370.3bDKK 107.0b36.1x42.6x12.3x
Thu, 11 Jul 2024DKK 4.9tDKK 355.3bDKK 106.2b35.6x46.3x13.9x
Sat, 08 Jun 2024DKK 4.9tDKK 355.3bDKK 106.2b36.2x46.5x13.9x
Mon, 06 May 2024DKK 4.3tDKK 354.8bDKK 106.4b33.9x40.9x12.3x
Wed, 03 Apr 2024DKK 4.5tDKK 341.2bDKK 99.6b38.4x44.7x13.1x
Fri, 01 Mar 2024DKK 4.2tDKK 340.1bDKK 98.9b38.2x42.9x12.5x
Sun, 28 Jan 2024DKK 3.8tDKK 320.5bDKK 90.0b34.7x42x11.8x
Tue, 26 Dec 2023DKK 3.6tDKK 320.4bDKK 90.0b32.8x40.2x11.3x
Thu, 23 Nov 2023DKK 3.6tDKK 320.5bDKK 90.0b32.7x40.4x11.4x
Sat, 21 Oct 2023DKK 3.5tDKK 305.5bDKK 82.2b27.8x42.6x11.5x
Mon, 18 Sep 2023DKK 3.5tDKK 305.5bDKK 82.2b36.6x42.9x11.5x
Wed, 16 Aug 2023DKK 3.3tDKK 301.3bDKK 81.0b40x40.9x11x
Fri, 14 Jul 2023DKK 2.9tDKK 286.9bDKK 75.4b38.3x38x10x
Sun, 11 Jun 2023DKK 3.0tDKK 287.1bDKK 75.5b40x39.9x10.5x
Tue, 09 May 2023DKK 3.2tDKK 284.0bDKK 74.5b40.3x42.5x11.1x
Thu, 06 Apr 2023DKK 3.0tDKK 272.4bDKK 68.5b39.4x43.5x10.9x
Sat, 04 Mar 2023DKK 2.8tDKK 292.6bDKK 69.2b39.4x40.7x9.6x
Mon, 30 Jan 2023DKK 2.7tDKK 275.9bDKK 66.3b37x40.4x9.7x
Wed, 28 Dec 2022DKK 2.7tDKK 276.0bDKK 66.3b36.5x40.1x9.6x
Fri, 25 Nov 2022DKK 2.5tDKK 276.2bDKK 66.3b37x37.6x9x
Sun, 23 Oct 2022DKK 2.3tDKK 261.3bDKK 62.4b34.9x36.9x8.8x
Tue, 20 Sep 2022DKK 2.2tDKK 261.2bDKK 62.4b33.5x35.8x8.5x
Thu, 18 Aug 2022DKK 2.3tDKK 257.4bDKK 62.6b34.7x37.4x9.1x
Sat, 16 Jul 2022DKK 2.5tDKK 247.9bDKK 59.9b37.4x41.2x9.9x
Price to Earnings Ratio

41.2x


Total Market Cap: DKK 2.5tTotal Earnings: DKK 59.9bTotal Revenue: DKK 247.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Healthcare Sector Price to Earnings3Y Average 37.8x202320242025
Current Industry PE
  • Investors are pessimistic on the Danish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 19.7x which is lower than its 3-year average PE of 37.8x.
  • The 3-year average PS ratio of 10.3x is higher than the industry's current PS ratio of 5.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 28% per year over the last three years.
  • Revenues for these companies have grown 20% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare sector?

DK Market2.04%
Healthcare2.34%
Healthcare Services7.39%
Biotech3.38%
Healthtech3.14%
Pharma2.51%
Medical Equipment0.74%
Life Sciences-3.35%
Industry PE
  • Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 102x.
    • Analysts are expecting annual earnings growth of 13.5%, which is lower than the prior year's growth of 17.6% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 60% over the next 5 years.
  • This is better than its past earnings decline of 83% per year.
  • In contrast, the Biotech industry is expected to see its earnings growth to stay flat over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVO B Novo NordiskDKK 443.050.4%
+DKK 6.9b		-54.6%PE18.8x
GMAB GenmabDKK 1.37k5.8%
+DKK 4.6b		-22.3%PE11.6x
ALK B ALK-AbellóDKK 191.002.7%
+DKK 1.1b		24.8%PE45.1x
BAVA Bavarian NordicDKK 175.603.8%
+DKK 502.1m		-6.1%PE10.3x
COLO B ColoplastDKK 602.800.1%
+DKK 135.1m		-30.8%PE29.9x

Latest News

CHEMM
DKK 546.00
ChemoMetec
7D
-2.8%
1Y
44.5%

ChemoMetec A/S' (CPH:CHEMM) Popularity With Investors Is Under Threat From Overpricing

Jul 07
ChemoMetec A/S' (CPH:CHEMM) Popularity With Investors Is Under Threat From Overpricing
GMAB
DKK 1,371.50
Genmab
7D
5.8%
1Y
-22.3%
BIOPOR
DKK 1.37
BioPorto
7D
-2.4%
1Y
-35.0%
GUBRA
DKK 415.00
Gubra
7D
-5.9%
1Y
-24.5%

Gubra A/S' (CPH:GUBRA) 35% Jump Shows Its Popularity With Investors

Jun 28
Gubra A/S' (CPH:GUBRA) 35% Jump Shows Its Popularity With Investors
ALK B
DKK 191.00
ALK-Abelló
7D
2.7%
1Y
24.8%
NOVO B
DKK 443.05
Novo Nordisk
7D
0.4%
1Y
-54.6%
ZEAL
DKK 365.10
Zealand Pharma
7D
0.2%
1Y
-61.7%
HLUN B
DKK 34.16
H. Lundbeck
7D
-5.3%
1Y
-15.7%
BAVA
DKK 175.60
Bavarian Nordic
7D
3.8%
1Y
-6.1%

Earnings Working Against Bavarian Nordic A/S' (CPH:BAVA) Share Price

Jun 13
Earnings Working Against Bavarian Nordic A/S' (CPH:BAVA) Share Price
DEMANT
DKK 266.20
Demant
7D
-1.5%
1Y
-10.8%
AMBU B
DKK 97.30
Ambu
7D
-3.1%
1Y
-26.3%
EMBLA
DKK 32.50
Embla Medical hf
7D
-4.4%
1Y
16.1%

Slowing Rates Of Return At Embla Medical hf (CPH:EMBLA) Leave Little Room For Excitement

Jun 10
Slowing Rates Of Return At Embla Medical hf (CPH:EMBLA) Leave Little Room For Excitement
PEG
DKK 0.12
Pharma Equity Group
7D
-11.4%
1Y
-60.4%
COLO B
DKK 602.80
Coloplast
7D
0.1%
1Y
-30.8%

Investors Still Waiting For A Pull Back In Coloplast A/S (CPH:COLO B)

May 25
Investors Still Waiting For A Pull Back In Coloplast A/S (CPH:COLO B)
NNIT
DKK 69.30
NNIT
7D
1.2%
1Y
-35.5%

These 4 Measures Indicate That NNIT (CPH:NNIT) Is Using Debt Reasonably Well

May 16
These 4 Measures Indicate That NNIT (CPH:NNIT) Is Using Debt Reasonably Well
STRAP
DKK 1,175.00
Strategic Partners
7D
17.5%
1Y
32.0%